InvestorsObserver
×
News Home

Should Biotechnology Stock Icosavax Inc (ICVX) Be in Your Portfolio Tuesday?

Tuesday, January 16, 2024 02:43 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Icosavax Inc (ICVX) Be in Your Portfolio Tuesday?

A rating of 94 puts Icosavax Inc (ICVX) near the top of the Biotechnology industry according to InvestorsObserver. Icosavax Inc's score of 94 means it scores higher than 94% of stocks in the industry. Icosavax Inc also received an overall rating of 79, putting it above 79% of all stocks. Biotechnology is ranked 35 out of the 148 industries.

Overall Score - 79
ICVX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on ICVX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 79 means the stock is more attractive than 79 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Icosavax Inc Stock Today?

Icosavax Inc (ICVX) stock has gained 0.26% while the S&P 500 is down -0.63% as of 2:43 PM on Tuesday, Jan 16. ICVX is up $0.04 from the previous closing price of $15.61 on volume of 303,289 shares. Over the past year the S&P 500 has gained 19.12% while ICVX is up 58.56%. ICVX lost -$2.22 per share the over the last 12 months. Click Here to get the full Stock Report for Icosavax Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App